Norma Bertoch | Posted: 8 Feb 2011 | Updated: 8 Nov 2020

Kaufusi Diagnosed with Hodgkin's Lymphoma

main image
Image


Click to watch the video.

PROVO -- BYU sophomore forward Alexis Kaufusi has been diagnosed with Hodgkin’s Lymphoma, and will not compete for the women’s basketball team the remainder of the season.

She’s played in a total of 20 games this year averaging 4.9 points and 2.8 rebounds. Kaufusi is undergoing additional testing to determine the best course of treatment.

“Our thoughts and prayers are with Alexis and her family at this time,” said head coach Jeff Judkins. “We wish her a quick recovery and want her to know that she has our love and support.”

Hodgkin's Lymphoma is a cancer of the lymphatic system, which is part of the immune system. Advances in diagnosis and treatment of Hodgkin's Lymphoma have helped to make this form of cancer highly treatable, with the potential for full recovery.

The family wishes to express their appreciation for all the support, well wishes and prayers during this time.

As a freshman in 2009-10, Kaufusi played in all 33 games averaging 16 minutes of playing time. She ranked first on the team in field goal percentage, recorded 10 double figure scoring games and posted two double-doubles.

For more information about Hodgkin’s Lymphoma,

Click Here

Recent Stories

Image
Emma Calvert races by a USF defender on the way to a 66-56 BYU win over the Dons.
BYU's big fourth quarter downs Dons 66-56, Cougars advance to WCC semifinal

Despite its top two scorers for the game on the bench with foul trouble, BYU outlasted any comeback attempts and beat…

Image
Lauren Gustin places BYU on the quarter-final seed line on the 2023 WCC Tournament bracket after beating Pepperdine.
BYU to face San Francisco for spot in WCC semi-final

BYU women's basketball will take on San Francisco at 1 p.m. in the quarterfinals of the 2023 University Credit Union…